StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — Nirav Chheda, Nirmal Bang Securities

BUYAarti Pharmalabs Limited
Aarti Pharmalabs share price target & all analyst calls

byNirav Chheda, Nirmal Bang SecuritiesHorizon: NA (inferred 1 year)29 Sept 2026via CNBC Awaaz.

Entry₹950.5Inferred
Target₹1,200
Total upside +26.25% (call closed)
Stop loss₹925-2.68% risk
Exit₹9251 Oct 2026, 12:10 pm
Stop-loss hit-2.68%
Follow Nirav Chheda for new callsGet alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 3 active Long-term calls on AARTIPHARMSee 273 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Sept 2026
3 supporting3 neutral0 opposing
Supports the BUY call (3)

Nothing found in this tip’s window yet.

Neutral / worth noting (3)

Aarti Pharmalabs Insider Ups Holding During Year

NewsGoogle News·16 Sept · 2w ago

(opens in new tab)

Dividend stocks alert, record date: Last chance to buy - Blue Dart, Karnataka Bank, Aarti Pharma, ITDC | Full list

NewsGoogle News·14 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Pharmalabs

All analyst calls on Aarti Pharmalabs

More from Nirav Chheda, Nirmal Bang Securities

Every call and its outcome